No Data
No Data
Mangoceuticals, Inc. Initiates Investigation Into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
Mangoceuticals | 10-Q: Q3 2024 Earnings Report
Mangoceuticals Signs Consulting Deal With CFO Johnston
Mangoceuticals Regains Full Compliance With Nasdaq Minimum Bid Price Requirement
Express News | Mangoceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Bid Price Requirement
Update: Mangoceuticals 'Strongly Refutes' Eli Lilly's Claims About Copying Weight-Loss Drugs
No Data
J L 7 2 : Not bad, not bad. Originally I was making money, but unfortunately due to manipulation, I ended up selling at a loss.
Trytosaveabit OP J L 7 2 : Yup! A lot of people have! And many spoke to company! I sure that helped them decide to investigate!